Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements

Withdrawn before enrolling

Conditions studied: Infection

In brief

The purpose of the study is to gather information on the use of Stimulan, the surgery, and anitbiotics to whetether the APPI has decreased or shown improvement when compared to study participants who did not receive Stimulan during their revision total knee replacement surgery.

Key facts

Study ID

NCT02107924

Run by

Michael Muldoon, M.D.

People needed

0

Starts

2014-04-01

Expected to finish

2015-12-01

Last updated by the study team

2014-11-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• APPI within 28 days of primary TKR
• Acute hematogenous infection within 4 weeks of symptoms

You may not qualify if…

• Exposed prosthesis
• Infection occuring in revised joints
• Poly articular infections
• have allergies to tobramycin or Vancomycin
• previous chronic infections in or around any ipsilateral extremity trauma or implants

Where it is running

• Southwest Orthopedic Group, LLP — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.